Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence for a slow elimination phase for penicillin G.

Literature DB >> 3392413

Evidence for a slow elimination phase for penicillin G.

S C Ebert¹, J Leggett, B Vogelman, W A Craig.

Abstract

Entities: Chemical

Mesh：

Substances：
Penicillin G

Year: 1988 PMID： 3392413 DOI： 10.1093/infdis/158.1.200

Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.

Authors: Anouk E Muller; Joost DeJongh; Ymka Bult; Wil H F Goessens; Johan W Mouton; Meindert Danhof; John N van den Anker
Journal: Antimicrob Agents Chemother Date: 2007-07-23 Impact factor: 5.191

2. Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD).

Authors: Oliver D Montagnat; Graham R Webster; Jürgen B Bulitta; Cornelia Landersdorfer; Rosemary Wyber; Meru Sheel; Jonathan R Carapetis; Ben J Boyd
Journal: Drug Deliv Transl Res Date: 2018-06 Impact factor: 4.617

3. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.

Authors: Elisabet I Nielsen; Otto Cars; Lena E Friberg
Journal: Antimicrob Agents Chemother Date: 2011-08-01 Impact factor: 5.191

10. Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis.

Authors: Toshiaki Komatsu; Takayuki Inomata; Ichiro Watanabe; Masahiro Kobayashi; Hideya Kokubun; Junya Ako; Koichiro Atsuda
Journal: J Pharm Health Care Sci Date: 2016-04-05

10 in total

Evidence for a slow elimination phase for penicillin G.

1. Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.

2. Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD).

3. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.

4. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery.

5. Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.

6. Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.

7. Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model.

8. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.

Review 9. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

10. Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis.